Dominique de Valeriola

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours

Ahmad Awada, Alain Hendlisz, Thierry Gil et al. · British Journal of Cancer · 2005 · 338 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

Eva Tomiak, Martine Piccart, Joseph Kerger et al. · Journal of Clinical Oncology · 1994 · 132 citations

Medicine, Oncology, Pharmacology +16

EORTC 10968: a phase I clinical and pharmacokinetic study of polyethylene glycol liposomal doxorubicin (Caelyx®, Doxil®) at a 6-week interval in patients with metastatic breast cancer

Anne Hamilton, Laura Biganzoli, Robert E. Coleman et al. · Annals of Oncology · 2002 · 106 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Tobacco: deadly in any form or disguise

Peter Boyle, MA Yasantha Ariyaratne, Ruth Barrington et al. · The Lancet · 2006 · 87 citations

Public Health, Preventive Medicine, Tobacco Control +1

Six-year results of a multimodality treatment strategy for locally advanced breast cancer

Martine Piccart, Dominique de Valeriola, Robert Paridaens et al. · Cancer · 1988 · 70 citations

Medicine, Oncology, Surgery +16